Track record · closed signal

UnitedHealth Group Incorporated (UNH) — closed signal from December 19, 2025

Partial Published before the outcome was known, scored automatically when the window closed on March 19, 2026.

Predicted vs. what happened

UNH price · publication thesis → realized outcomesplit-adjusted
$331.23 Published $380.91 Target $280.44 Window close $357.87 Peak
$320.00 – $338.00Entry zone — fair-value band
$331.23Published — price the day we called it
$380.91Target — the price the thesis aimed for
$357.87Peak — highest point inside the window, not a realized return
$280.44Window close — end-of-window price, context only

What happened

Partial

Reached 53% of the predicted growth at its peak, without hitting the target.

Peak price
$357.87
peak on January 23, 2026 — not a realized return
Peak gain
+8%
peak, from the publication price
Window close
$280.44
end-of-window price, context only
Days to target
Window
December 19, 2025 – March 19, 2026

The thesis — published December 19, 2025

Predicted growth
+15%
over the measurement window
Target price
$380.91
the price the thesis aimed for
Entry zone
$320.00 – $338.00
the fair-value band we waited for
Price at publication
$331.23
published December 19, 2025
Confidence
67%
how strongly the data lined up
Timeframe
Short-term (0–3 months)

UnitedHealth looks like a short-term rebound after a sharp fall. The company announced operational fixes on 2025-12-19 after outside audits, which could calm investors and reduce some process-related risk. The stock may be undervalued now, but future headlines about regulation or rising medical costs could wipe out the recovery quickly.

Primary drivers

  • Operational fixes after audits could steady performance
  • Very oversold stock can attract fast buying to cover shorts
  • Lower valuation after the drop may draw reversion trades
  • Regulatory or medical cost headlines can reverse gains quickly

How it played out

UNH: rebound stalled below target

Lyra published UNH at 331.23 on 2025-12-19 as a short-term rebound idea with 15% expected growth. The thesis pointed to operational fixes after audits, oversold trading, a lower valuation after the drop, and the risk that regulation or medical cost headlines could reverse gains quickly.

Inside the window, UNH rose to 357.87 on 2026-01-23, a peak gain of 8%. It stayed below the 380.91 target. By 2026-03-19, it ended at 280.44. The rebound happened, but not enough to reach the target, and the final price was below the published price. The thesis only partially played out.

What happened during the window

On January 22, 2026, The Guardian reported that UnitedHealth's CEO testified before the House Energy and Commerce Committee during a hearing on rising healthcare costs. On January 27, 2026, MarketWatch reported that health insurer shares fell after CMS proposed a 0.09% Medicare Advantage payment increase for 2027.

Prices are shown split- and dividend-adjusted, matching what public charts show today.

Share this receipt

A scored call, published before the outcome was known. Paste the link anywhere — it unfurls as the card above.

Lyra

Read the next call before it closes.

This is one signal, scored after the fact. Today’s picks come with the same plain-language thesis — published before anyone knows the outcome.